Ascelia Pharma Expands Orviglance IP Portfolio with New Patent Filing

MALMÖ, SE / ACCESS Newswire / June 30, 2026 / Ascelia Pharma AB (publ) (STO:ACE), a biotech company focused on improving the life of people living with rare cancer conditions, today announced the filing of a new patent application for its …